Insider Selling: Avanos Medical, Inc. (NYSE:AVNS) SVP Sells 7,000 Shares of Stock

Avanos Medical, Inc. (NYSE:AVNS) SVP Kerr Holbrook sold 7,000 shares of the company’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the sale, the senior vice president now directly owns 82,047 shares in the company, valued at $1,251,216.75. This trade represents a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Avanos Medical Price Performance

AVNS traded down $0.12 during trading on Monday, hitting $15.12. 226,145 shares of the stock traded hands, compared to its average volume of 541,257. Avanos Medical, Inc. has a twelve month low of $14.40 and a twelve month high of $25.36. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. The business has a 50 day moving average price of $16.01 and a 200 day moving average price of $19.30. The company has a market cap of $695.43 million, a price-to-earnings ratio of 44.59 and a beta of 1.17.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The business had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Equities research analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Avanos Medical

A number of hedge funds have recently modified their holdings of AVNS. Quarry LP bought a new position in shares of Avanos Medical in the third quarter worth $42,000. Quantbot Technologies LP purchased a new position in Avanos Medical during the 4th quarter valued at $64,000. KBC Group NV lifted its holdings in Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after buying an additional 1,095 shares during the period. State of Wyoming grew its stake in Avanos Medical by 132.0% in the fourth quarter. State of Wyoming now owns 5,137 shares of the company’s stock worth $82,000 after purchasing an additional 2,923 shares during the period. Finally, Tower Research Capital LLC TRC increased its stake in shares of Avanos Medical by 493.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company’s stock worth $129,000 after acquiring an additional 6,714 shares in the last quarter. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.